FDA Clears Dermalogica PRO Pen Microneedling Device
The Class II medical device will be available in the US starting in 2026, marking the company's expansion into medical aesthetics.
The Class II medical device will be available in the US starting in 2026, marking the company's expansion into medical aesthetics.
The partnership provides HIPAA-compliant insights and automated retention campaigns by combining lead, patient, and EMR data into a single dashboard.